AbGn-207

Therapeutic Area

Product Overview
AbGn-207 is designed as a CAR T-cell therapy.

Indication

GI Tumors

1

  • PRECLINICAL

    Preclinical

  • PHASE I

  • PHASE IIA

  • PHASE IIB

  • PHASE III

  • MARKET